Metacard MR Description

trimetazidine

Manufacturer:

Distributor:

KTZ

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Contraindications Use In Pregnancy & Lactation Side Effects Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Description

Each modified release tablet contains Trimetazidine Hydrochloride BP 35 mg.
Metacard MR Tablet (Trimetazidine Hydrochloride) is the new twice-daily formulation of the first 3-keto acyl Co-A thiolase inhibitor (KAT), a metabolic anti-ischemic agent with proven benefits for all coronary patients.

Asia's one-stop resource for medical news, clinical reference and education

Already a member? Sign in